Keyphrases
Osteosarcoma
100%
Novel Therapeutics
100%
Metabolic Reprogramming
100%
Pramlintide
100%
Osteosarcoma Cells
57%
Human Islet Amyloid Polypeptide (hIAPP)
42%
Apoptosis
28%
Tumor Regression
28%
Glycolysis
28%
Glycolytic Activity
28%
Mouse Model
14%
Tumor
14%
Induced Apoptosis
14%
Inhibit Tumor
14%
Tumor Growth
14%
Combination Chemotherapy
14%
Ki-67
14%
Hypoxia-inducible factor-1α (HIF-1α)
14%
FDA-approved Drugs
14%
Clinical Trials
14%
TP53 mutation
14%
Tumor Metabolism
14%
Surgical Outcomes
14%
Type 2 Diabetes Mellitus (T2DM)
14%
New Therapies
14%
TP53 Deletion
14%
Intratumoral Injection
14%
Tumor Section
14%
Combined Surgery
14%
Chemotherapy Outcomes
14%
Glycolytic
14%
Metabolic Programming
14%
High Range
14%
Mid-range
14%
RAMP3
14%
CALCR
14%
Pharmacology, Toxicology and Pharmaceutical Science